[Breast] MRI in the Prediction of Pathological Complete Response in Breast Cancer Patients after Neoadjuvant Chemotherapy

Ki Jo Kim

대한외과학회 학술대회 초록집

2022 .11

Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer

이용표 ,  이민상 ,  김홍식 외 4명

Cancer Research and Treatment

2022 .10

Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response

Elnem ,  Gamal M ,  El-Rashidy 외 18명

Asian Pacific journal of cancer prevention : APJCP

2016 .01

Predictive Factor of the Pathologic Complete Response after the Neoadjuvant Treatment of the HER2 Positive Breast Cancer

Dong Won Im ,  Youn Joo Jung ,  Hyun Yul Kim 외 3명

대한외과학회 학술대회 초록집

2022 .05

Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy

Xinyan Li ,  Mozhi Wang ,  Mengshen Wang 외 6명

Journal of Breast Cancer

2019 .01

Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab

하주영 ,  김정은 ,  이희진 외 9명

Journal of Breast Cancer

2021 .08

Biomarkers That Predict an Unclear Benefit From Adjuvant Trastuzumab, Pertuzumab and Pembrolizumab When Those Same Drugs Were Given Neoadjuvantly

Steven So ,  sche

Journal of Breast Cancer

2023 .02

Erratum: Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer

Chuqian Lei ,  Ciqiu Yang ,  Bin Xia 외 11명

Journal of Breast Cancer

2020 .01

Recent Advances in the Neoadjuvant Treatment of Breast Cancer

Gábo ,  Rubovszky ,  Zsolt Ho 외 1명

Journal of Breast Cancer

2017 .01

The Role of Neoadjuvant Chemotherapy in Patients with ER Positive and HER2 Negative Breast Cancer

Hyunju KIM ,  Kyu Min KANG ,  Su Min CHAE 외 4명

대한외과학회 학술대회 초록집

2018 .11

Radiologic complete response after neoadjuvant chemotherapy in advanced breast cancer can predict survival outcome, but not pathologic complete response

Jinsun Woo ,  Jai Min Ryu ,  Se Kyung Lee 외 5명

대한외과학회 학술대회 초록집

2019 .10

Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis

박원영 ,  김한조 ,  김경하 외 6명

Cancer Research and Treatment

2016 .01

What Should We Do, If We Cannot Find The Tumor after Neoadjuvant Therapy?

Dong-Sik KIM

대한외과학회 학술대회 초록집

2019 .10

Prediction of Axillary Lymph Node Response Based on Breast Pathologic Complete Response and Breast Cancer Subtype after Neoadjuvant Chemotherapy

Jai Min Ryu ,  Hee Jun Choi ,  Se Kyung Lee 외 4명

대한임상종양학회 학술대회지

2019 .02

Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy

박철근 ,  정우희 ,  구자승

Journal of Pathology and Translational Medicine

2016 .01

[Breast] Risk Factors of Breast Cancer Recurrence in Pathologic Complete Response (pCR) Achieved Post Neoadjuvant Chemotherapy (NAC) Patients

Doyoun Woen

대한외과학회 학술대회 초록집

2022 .11

Benefits of Adjuvant Trastuzumab in HER2-Positive Breast Cancer with pT1a-bN0M0 : A Systematic Review and Meta-Analysis of Published literatures

Chai Hong Rim ,  Hye Yoon Lee

대한외과학회 학술대회 초록집

2018 .11

Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study

Ruyan Zhang ,  Xiao ,  an Liu 외 3명

Cancer Research and Treatment

2024 .07

Predictive Factors of Pathologic N2/N3 Disease in Clinical or Pathologic N1 ER+/HER2- Breast Cancer

Jeongseop Lee ,  Khwanho Lee

대한외과학회 학술대회 초록집

2023 .05

Breast Cancer

Yoo Seok Kim

대한외과학회 학술대회 초록집

2022 .11